Key result
Implementation of a critical pathways-based management program for acute coronary syndromes reduced recurrent angina symptoms from 28.5% to 13% and nonfatal MI from 15% to 5%.
Why the study?
Does a critical pathways-based management program improve guideline compliance and clinical outcomes in patients admitted for acute coronary syndromes?
Cohort
No
Does a critical pathways-based management program improve guideline compliance and clinical outcomes in patients admitted for acute coronary syndromes?
Implementation of a critical pathways-based management program for acute coronary syndromes significantly improves adherence to guideline-directed medical therapy and reduces recurrent angina and nonfatal myocardial infarction at 1 year.
Answers are grounded in this paper and cite their sources.
May support pathways in ACS; hypothesis-generating without randomized confirmation.
We describe our experience with the Advanced Cardiac Admission Program (ACAP) at our institution. The ACAP program is a hospital-wide implementation of critical pathways-based management of all cardiac patients. Data review of patients admitted for acute coronary syndromes from the ACAP-PAIN database and a comparative study of outcomes before and after implementation of the pathways-based assessment and treatment protocols. In the pre-ACAP and post-ACAP patient groups, antiplatelet use at admission improved from 50% to 75% (p<.01), ACE-I use improved from 32% to 54% (p<.0001), statins use increased from 35% to 62% (p<.0001), and smoking cessation awareness increased from 15% to 86% (p<.0001). At 1-year follow-up, 84% of patients with CAD were treated with statins, and 47% had LDL cholesterol <100 mg/dL, compared with 20% and 9%, respectively, with conventional treatment before ACAP implementation (p<.0001). Recurrent angina symptoms and nonfatal myocardial infarction rates decreased from 28.5% to 13% (p = .02), and 15% to 5% (p = 0.03), respectively. Pathway-based programs like ACAP significantly enhance administration of guidelines-based cardioprotective medications both during hospital stay and at 1-year follow-up.
No takes yet. Share an insight, caveat, or question.
Aziz et al. (2011) conducted a cohort in Acute coronary syndromes. Advanced Cardiac Admission Program (ACAP) critical pathways-based management vs. Conventional treatment before ACAP implementation was evaluated on Recurrent angina symptoms (p=0.02). Implementation of a critical pathways-based management program for acute coronary syndromes reduced recurrent angina symptoms from 28.5% to 13% and nonfatal MI from 15% to 5%.
Synapse has enriched 10 related papers. Consider them for comparative context: